In AGC1-4, in whom cKD was initiated because of therapy refractory epilepsy when the genetic diagnosis was still unknown, cKD was stopped after 1 month because of intolerance (vomiting and gastrointestinal problems) and lack of efficacy. The gene discussed is SLC25A12; the disease is chronic kidney disease.